Evidence map›Paper›PMID 31022948›Full record

ArticleViruses2019

Lack of Middle East Respiratory Syndrome Coronavirus Transmission in Rabbits.

W Widagdo, Nisreen M A Okba, Mathilde Richard, Dennis de Meulder, Theo M Bestebroer, Pascal Lexmond, Elmoubasher A B A Farag, Mohammed Al-Hajri, Koert J Stittelaar, Leon de Waal and 4 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Variable DPP4 expression in multiciliated cells of the human nasal epithelium as a determinant for MERS-CoV tropism.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

W WidagdoDepartment of Viroscience, Erasmus Medical Center, 3015GD Rotterdam, The Netherlands. w.widagdo@erasmusmc.nl.ORCID 0000-0003-1572-8793
Nisreen M A OkbaDepartment of Viroscience, Erasmus Medical Center, 3015GD Rotterdam, The Netherlands. n.okba@erasmusmc.nl.ORCID 0000-0002-2394-1079
Mathilde RichardDepartment of Viroscience, Erasmus Medical Center, 3015GD Rotterdam, The Netherlands. m.richard@erasmusmc.nl.
Dennis de MeulderDepartment of Viroscience, Erasmus Medical Center, 3015GD Rotterdam, The Netherlands. d.demeulder@erasmusmc.nl.
Theo M BestebroerDepartment of Viroscience, Erasmus Medical Center, 3015GD Rotterdam, The Netherlands. t.bestebroer@erasmusmc.nl.
Pascal LexmondDepartment of Viroscience, Erasmus Medical Center, 3015GD Rotterdam, The Netherlands. p.lexmond@erasmusmc.nl.
Elmoubasher A B A FaragMinistry of Public Health, Doha, Qatar, PO Box. 42. eabdfarag@MOPH.GOV.QA.
Mohammed Al-HajriMinistry of Public Health, Doha, Qatar, PO Box. 42. malhajri1@MOPH.GOV.QA.
Koert J StittelaarViroclinics Biosciences BV, Rotterdam 3029 AK, The Netherlands. stittelaar@viroclinics.com.
Leon de WaalViroclinics Biosciences BV, Rotterdam 3029 AK, The Netherlands. dewaal@viroclinics.com.
Geert van AmerongenViroclinics Biosciences BV, Rotterdam 3029 AK, The Netherlands. amerongen@viroclinics.com.
Judith M A van den BrandDepartment of Viroscience, Erasmus Medical Center, 3015GD Rotterdam, The Netherlands. j.m.a.vandenbrand@uu.nl.
Bart L HaagmansDepartment of Viroscience, Erasmus Medical Center, 3015GD Rotterdam, The Netherlands. b.haagmans@erasmusmc.nl.ORCID 0000-0001-6221-2015
Sander HerfstDepartment of Viroscience, Erasmus Medical Center, 3015GD Rotterdam, The Netherlands. s.herfst@erasmusmc.nl.ORCID 0000-0001-9866-8903
Viroclinics Biosciences (Netherlands) · NLMinistry of Public Health · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) transmission from dromedaries to humans has resulted in major outbreaks in the Middle East. Although some other livestock animal species have been shown to be susceptible to MERS-CoV, it is not fully understood why the spread of the virus in these animal species has not been observed in the field. In this study, we used rabbits to further characterize the transmission potential of MERS-CoV. In line with the presence of MERS-CoV receptor in the rabbit nasal epithelium, high levels of viral RNA were shed from the nose following virus inoculation. However, unlike MERS-CoV-infected dromedaries, these rabbits did not develop clinical manifestations including nasal discharge and did shed only limited amounts of infectious virus from the nose. Consistently, no transmission by contact or airborne routes was observed in rabbits. Our data indicate that despite relatively high viral RNA levels produced, low levels of infectious virus are excreted in the upper respiratory tract of rabbits as compared to dromedary camels, thus resulting in a lack of viral transmission.

Indexed as

Specific Pathogen-Free OrganismsAnimalsAntibodies, ViralCamelusCoronavirus InfectionsDisease ReservoirsFemaleMaleMiddle East Respiratory Syndrome CoronavirusNoseRabbitsRespiratory SystemRNA, ViralVirus SheddingAntibodies, ViralRNA, ViralMERS-coronavirusrabbitstransmission

Identifiers

PMID31022948
PMCPMC6520746
OpenAlexW2941884220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.